MedTrace Logo

Psychological Treatment Targeting Acceptance and Compassion in Chronic Pain Patients

NCT03504904 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2019-08-22

No results posted yet for this study

Summary

This trial is a randomized controlled study aiming to investigate the effect of an 8-week internet-based intervention focused on acceptance and compassion or a wait-list control group. Primary treatments outcomes are Chronic Pain Acceptance Questionnaire (CPAQ), Self-Compassion Scale (SCS) and Pain Disability index (PDI). Secondary outcomes were Montgomery Åsberg Depression Rating Scale (MADRS-S), Anxiety sensitivity index (ASI), Quality of Life Inventory (QOLI), Multidimensional Pain Inventory (MPI) and Perseverative Thinking Questionnaire (PTQ). A six month follow-up was conducted. Findings showed significantly greater levels of acceptance (CPAQ), self-compassion (SCS) and reduction in activity limitation (PDI) measured with the primary outcomes for the treatment group after the intervention with effect sizes raging from small to moderate and these results were maintained at six-month follow-up.

Conditions

Interventions

BEHAVIORAL

Internet-Delivered ACT and CFT

An 8-week internet-based intervention focused on acceptance and compassion. Psychological intervention based on Acceptance and commitment therapy and compassion focused therapy

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

  • Uppsala University Hospital

    collaborator OTHER

  • Örebro University, Sweden

    collaborator OTHER

  • Karlstad University

    collaborator OTHER

Principal Investigators

  • Monica Buhrman, PhD · Uppsala University

  • Katja Boersma, PhD · Örebro University, Sweden

  • Maria Tillfors, PhD · Karlstad University

  • Fredrik Holländare, PhD · Örebro University, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-13
Primary Completion
2016-01-23
Completion
2016-01-23

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03504904 on ClinicalTrials.gov